Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Why Merck (NYSE:MRK) Fell on the Dow: Its Moderna Partnership Became a Sell-the-News Story

● The Phase 3 trial tested the vaccine alongside Merck's Keytruda in over 1,100 patients.

Nitish Kishor | 23 October 2026

Why Pharming Group (NASDAQ:PHAR) Jumped on the Nasdaq Composite After Preliminary Quarterly Revenue

● That is a morning snapshot rather than a confirmed closing price.

Nitish Kishor | 23 October 2026

Why Did Auna (NYSE:AUNA) Shares Tumble as the Broad Market Turned Defensive?

● Auna is a Latin American healthcare-services company.

Nitish Kishor | 23 October 2026

Avalo Therapeutics (NASDAQ:AVTX) Plunges to a 52-Week Low on Pipeline Setback

● The stock carved out a fresh 52-week low.

Nitish Kishor | 23 October 2026

What Investors Are Watching at LeonaBio (NASDAQ:LONA) After a Clinical-Stage Slide

● LeonaBio is a clinical-stage micro-cap biotech whose shares trade on sentiment and expectations.

Nitish Kishor | 23 October 2026

NewGenIvf Group (NASDAQ:NIVF) Slips as a Thinly Traded Micro-Cap

● NewGenIvf is a sub-dollar healthcare micro-cap where a penny moves the price sharply.

Nitish Kishor | 23 October 2026

Picard Medical (NYSE American:PMI) Stock: Shares Decline Amid Small-Cap Volatility

● Picard Medical is a small-cap medical name where low float can drive outsized percentage moves.

Nitish Kishor | 23 October 2026

Why Did China SXT Pharmaceuticals (NASDAQ:SXTC) Stock Tumble on Thursday?

● A thin pool of available shares and a low nominal price magnify its swings.

Nitish Kishor | 23 October 2026

What Investors Are Watching at Armata Pharmaceuticals (NYSE American:ARMP) After a Jump

● Armata is a clinical-stage micro-cap biotech with a thinly traded, low-priced stock.

Nitish Kishor | 23 October 2026

Avalyn Pharma (NASDAQ:AVLN) Jumps on Speculative Flows

● Avalyn is a clinical-stage biopharmaceutical company.

Nitish Kishor | 23 October 2026
Support

Hi! How can we help you today?

Loading…